Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 11, 2021
Quotient Sciences has acquired Arcinova, a U.K.-based multiservice CDMO.
read more
Quotient Clinical, the Translational Pharmaceutics Company, has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development. Quotient will employ its real-time, flexible manufacturing capabilities...
read more
Friday, November 15, 2013
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – has announced a significant expansion of its capacity and capabilities.
read more
Saturday, September 25, 2021
Quell Therapeutics, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced it has entered a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult). The ...
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
Tuesday, November 08, 2022
Quanticate, a global data-focused clinical research organization (CRO), has announced plans for further expansion and new jobs in 2023 as it thrives post-pandemic.
read more
Quanterix announced the relocation of its headquarters to a brand new facility in Billerica, Mass.
read more
Thursday, November 05, 2020
Qualigen has signed a contract with WuXi STA for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
read more
Tuesday, November 28, 2017
Quad Technologies has opened a new, larger headquarters and laboratory that allows the company to expand manufacturing capabilities for QuickGel.
read more
Qosina announced that it has entered into a distribution agreement with Nordson MEDICAL, a manufacturer and supplier of components to the bioprocess and medical device industries. Qosina offers low minimum order quantities, providing a cost-effective...
read more
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce an Irradiate to Order service for its single-use bioprocess component portfolio.
read more
QHP Capital, the management company for NovaQuest Private Equity, announced its acquisition of Lexitas Pharma Services, a full-service ophthalmology contract research organization (“CRO”) supporting biopharmaceutical and medical device clinical ...
read more
Thursday, August 27, 2020
Q BioMed announced Mannin Research has been initiated for MAN-19, a clinical grade therapeutic intended to treat complications caused by COVID-19.
read more
Friday, September 13, 2019
Q BioMed and Chemveda have formalized a collaboration to continue the develop chemotherapy for the treatment of liver cancer and scale-up manufacturing of the cGMP product.
read more